INFI - Infinity Pharmaceuticals Inc. (INFI) CEO Adelene Perkins on Q3 2019 Results - Earnings Call Transcript
Infinity Pharmaceuticals, Inc. (INFI)
Q3 2019 Earnings Conference Call
October 30, 2019 04:30 PM ET
Company Participants
Jayne Kauffman - Senior Executive Coordinator
Adelene Perkins - CEO
Lawrence Bloch - President
Jeff Kutok - Chief Scientific Officer
Conference Call Participants
Matthew Bannon - J.P. Morgan
Kevin DeGeeter - Oppenheimer
Soumit Roy - JonesTrading
Nick Abbott - Wells Fargo Securities LLC
James Molloy - Alliance Global Partners
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the Company's Financial Results for the Third Quarter 2019. My